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ABSTRACT
Background: Microvascular obstruction (MVO) and
intramyocardial haemorrhage (IMH) are associated with
adverse prognosis, independently of infarct size after
reperfused ST-elevation myocardial infarction (STEMI).
Mitral annular plane systolic excursion (MAPSE) is a
well-established parameter of longitudinal function on
echocardiography.
Objective: We aimed to investigate how acute
MAPSE, assessed by a four-chamber cine-
cardiovascular MR (CMR), is associated with MVO,
IMH and convalescent left ventricular (LV) remodelling.
Methods: 54 consecutive patients underwent CMR at
3T (Intera CV, Philips Healthcare, Best, The
Netherlands) within 3 days of reperfused STEMI. Cine,
T2-weighted, T2* and late gadolinium enhancement
(LGE) imaging were performed. Infarct and MVO extent
were measured from LGE images. The presence of IMH
was investigated by combined analysis of T2w and T2*
images. Averaged-MAPSE (medial-MAPSE+lateral-
MAPSE/2) was calculated from 4-chamber cine
imaging.
Results: 44 patients completed the baseline scan and
38 patients completed 3-month scans. 26 (59%)
patients had MVO and 25 (57%) patients had IMH.
Presence of MVO and IMH were associated with lower
averaged-MAPSE (11.7±0.4 mm vs 9.3±0.3 mm;
p<0.001 and 11.8±0.4 mm vs 9.2±0.3 mm; p<0.001,
respectively). IMH (β=−0.655, p<0.001) and MVO
(β=−0.567, p<0.001) demonstrated a stronger
correlation to MAPSE than other demographic and
infarct characteristics. MAPSE ≤10.6 mm
demonstrated 89% sensitivity and 72% specificity for
the detection of MVO and 92% sensitivity and 74%
specificity for IMH. LV remodelling in convalescence
was not associated with MAPSE (AUC 0.62, 95% CI
0.44 to 0.77, p=0.22).
Conclusions: Postreperfused STEMI, LV longitudinal
function assessed by MAPSE can independently
predict the presence of MVO and IMH.
INTRODUCTION
Following reperfused acute myocardial
infarction (AMI), the left ventricle (LV)
undergoes structural adaptations both within
and outside of the infarct zone, referred to
as LV remodelling. In approximately 30% of
patients, coronary reperfusion is associated
with microvascular obstruction (MVO).1
KEY QUESTIONS
What is already known about this subject?
▸ Microvascular obstruction and intramyocardial
haemorrhage are independent adverse prognos-
tic markers after reperfused ST-elevation myo-
cardial infarction.
▸ Both these pathological process affect predom-
inantly the subendocardium.
▸ Subendocardial myocardial fibres are predomin-
antly longitudinal and mainly contribute to the
global left ventricular longitudinal function.
▸ Mitral annular plane systolic excursion (MAPSE)
is a marker of left ventricular longitudinal
function.
What does this study add?
▸ Left ventricular longitudinal function assessed
by MAPSE is independently associated with
microvascular obstruction and intramyocardial
haemorrhage.
▸ Acute left ventricular longitudinal function does
not demonstrate association with adverse left
ventricular remodelling.
▸ A cut-off of 10.6 mm for averaged-MAPSE was
89% sensitive and 72% specific for the detec-
tion of microvascular obstruction and was 92%
sensitive and 74% specific for the detection of
intramyocardial haemorrhage.
How might this impact on clinical practice?
▸ MAPSE can be evaluated at bedside by routine
echocardiography and is associated with the
presence of prognostic bioimaging markers.
▸ High-risk patients identified with MAPSE may
benefit from further more detailed imaging
assessment.
▸ Further research is needed to evaluate how this
patient group should be managed.
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Reperfusion may also lead to intramyocardial haemor-
rhage (IMH) in the infarct core2 associated with extrava-
sation of blood.3 MVO and IMH are associated with
adverse prognosis and adverse LV remodelling, inde-
pendently of infarct size.4–6
Acute myocardial ischaemia initially affects the suben-
docardium and progresses to the subepicardial layers in a
‘wave front’ manner.7 8 Similarly, MVO and IMH predom-
inantly affect the subendocardial layer. Endocardial ﬁbres
are structurally longitudinal ﬁbres9 and therefore pre-
dominantly contribute to longitudinal contractile func-
tion of the LV.10 MVO and IMH are therefore likely to
affect predominantly longitudinal function11 (ﬁgure 1).
Mitral annular plane systolic excursion (MAPSE) is a
well-established and easily obtained echocardiographic
parameter for the assessment of longitudinal function
and has been shown to correlate with LV systolic func-
tion.12 Post-AMI, MAPSE has prognostic importance in
the risk stratiﬁcation of patients, for example, a MAPSE
of <8 mm is associated with a >3× higher incidence of
hospitalisation and mortality (p=0.0001).13
Traditionally, longitudinal functional assessment using
MAPSE has been based on M-mode transthoracic echocar-
diography. It can also be evaluated from a standard four-
chamber cardiovascular MR (CMR) cine image. CMR-based
MAPSE is easily measured, reproducible and strongly cor-
relates with the echocardiographic equivalent.14 15
We sought to investigate the effect of MVO and IMH
on MAPSE in patients with acute STEMI and to deter-
mine correlations of CMR derived MAPSE with other
markers of adverse outcome.
METHODS
Patient selection
Patients presenting with ﬁrst ST-segment elevation AMI
who were revascularised by primary percutaneous coron-
ary intervention (PPCI) within 12 h of onset of chest
pain were prospectively recruited from a single tertiary
centre. AMI was deﬁned as per current guidelines.16
Exclusion criteria were previous AMI or coronary artery
bypass grafting, cardiomyopathy, estimated glomerular
ﬁltration rate <30 mL/min/1.73 m2, haemodynamic
instability or any contraindication to CMR. The study
protocol was approved by the institutional research
ethics committee and complied with the Declaration of
Helsinki. All patients gave written informed consent to
participate in this study. After PPCI, patients received
standard post-AMI secondary prevention therapy and
were enrolled in a cardiac rehabilitation programme.17
Image acquisition
All patients had CMR imaging at 3.0T (Achieva TX,
Philips Healthcare, Best, the Netherlands) within 3 days
(median 2 days) of their index presentation. A dedicated
32-channel cardiac phased array receiver coil was used.
Cine imaging was performed using a balanced
steady-state free precession (SSFP) pulse sequence with
a spatial resolution of 1.6×2.0×10 mm and 40 phases per
cardiac cycle. A four-chamber cine was planned perpen-
dicular to the ventricular long axis and through the
mitral annular plane and the LV apex.
T2w, T2* and late gadolinium enhancement (LGE)
imaging were performed using the ‘3-of-5’ approach by
acquiring the central 3 slices of 5 parallel short-axis
slices spaced equally from mitral valve annulus to LV
apical cap.18 0.1 mmol/kg gadolinium-DTPA (gadopen-
tetate dimeglumine; Magnevist, Bayer, Berlin, Germany)
was then administered using a power injector (Spectris,
Solaris, Pennsylvania, USA). LGE imaging was per-
formed at 16–20 min following contrast administration.
For each pulse sequence, images with artefact were
repeated until any artefact was removed or minimised.
The highest quality images were used for analysis.
Image analysis
Cine, T2w, T2* and LGE images were evaluated ofﬂine
using commercially available software (cvi42 v4.1.5,
Circle Cardiovascular Imaging Inc., Calgary, Canada).
Left ventricular volumes and ejection fraction (EF) were
analysed from cine images using standard methods.19
Infarct location was determined by LGE imaging,
according to standard guidelines.20 The presence and
size of infarction and MVO were measured from LGE
images. Infarct was deﬁned as an area of LGE ≥2 SDs
(SD) above remote myocardium, and infarct volume esti-
mation included any hypointense core. We used the 2
SD method over the full-width halve maximum method
as there is more prognostic data for the 2 SD infarct size
estimation.21 The 2 SD cut-off was chosen for consist-
ency with analysis of T2w images. MVO was deﬁned visu-
ally as a hypointense core within the infarcted zone on
LGE images and planimetered manually. Volumes of
infarct and MVO were calculated from planimetered
Figure 1 Illustration of orientation of myocardial fibres9 in
long-axis view with representation of infarct related zones. LV,
left ventricular.
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areas across the whole LV stack by the modiﬁed
Simpson’s method. The presence and extent of myocar-
dial haemorrhage was assessed by combined analysis of
T2w and T2* sequences.8 On T2w images, areas with
mean signal intensity more than 2 SD below the periph-
ery of the area at risk were considered to represent
haemorrhage.22 On the T2* images, the presence of a
dark core within the infarcted area by visual inspection
of the images was used as conﬁrmation of myocardial
haemorrhage. Only when T2w and T2* images showed
concordant ﬁndings was an area considered to represent
haemorrhage. Presence of MVO and IMH were scored
in a binominal mode.
For longitudinal functional assessment, the four-
chamber cine images were used (ﬁgure 2). A
region-of-interest (ROI) line was drawn across the
medial and lateral mitral annulus as a reference point in
end-diastole ( just after closure of mitral valve). A second
ROI line was drawn across the same plane on an image
taken just after closure of the aortic valve, assessed from
the LV outﬂow tract cine. The longitudinal distance
between the two lines parallel to the left ventricular
walls was measured for medial and lateral walls. For
MAPSE, three parameters were assessed—septal wall
MAPSE; lateral wall MAPSE and averaged-MAPSE
(medial-MAPSE+lateral-MAPSE)/2).
Longitudinal functional assessment was carried out
independently by two physicians experienced in both
echocardiography and CMR imaging (PG, 5-year experi-
ence; JRJF, 4-year experience). For intraobserver variabil-
ity assessment, one observer (PG) repeated the analysis
after 90-days, blinded to the original results. Patients
with suboptimal four-chamber cine images were
excluded from analysis.
Follow-up scans
Follow-up scans were planned at 3 months following the
indexed event. For analysis, patients were divided into
two groups based on the presence of LV remodelling,
deﬁned by the following: (A) an increase of LV end-
diastolic volume >20% at 3 months’ follow-up scan or
(B) as increase of LV end-systolic volume >20% at
3 months’ follow-up scan.
Statistical analysis
Statistical analysis was performed using IBM SPSS
Statistics V.21.0. Continuous variables are expressed as
mean±SD. Normal distribution for quantitative data was
established using the Kolmogorov-Smirnov test.
Demographic comparisons were performed with an inde-
pendent and paired two-sample t test. For follow-up data,
the paired two-sample t test was used to investigate differ-
ences. Multivariate linear regression was used for vari-
ables with statistical signiﬁcance from univariate analysis
(p<0.1). The strength of a linear association between two
variables was tested using Pearson’s correlation coefﬁ-
cient (r). The accuracy of averaged-MAPSE in predicting
presence of MVO and IMH was examined using receiver-
operator characteristic curve analyses, using Medcalc
(v14.12.0). Intra/interobserver variability was tested
using coefﬁcient of variation (CoV). All statistical tests
were 2-tailed; p values <0.05 were considered signiﬁcant.
RESULTS
Fifty four patients met the inclusion criteria. In ﬁve
patients the infarct size was too small for accurate ana-
lysis; in another ﬁve patients the four-chamber cine was
of insufﬁcient quality for longitudinal functional analysis
Figure 2 Multiparametric CMR examination of two cases of ST-elevation myocardial infarction. Case 1 (top row): Case of
inferior-lateral MI with presence of MVO on early gadolinium enhancement imaging (A) and LGE (B). IMH within MVO was
confirmed on T2-weighted maps (C) and T2*-maps (D). 4-chamber cine imaging (E) confirmed reduced averaged-MAPSE
(overlay of systolic and diastolic annular position shown in green). Case 2: Case of inferior MI without the presence of MVO (F
and G) or IMH (H and I) and comparatively better longitudinal displacement than case 1 ( J). CMR, cardiovascular MR; IMH,
intramyocardial haemorrhage; LGE, late gadolinium enhancement; MAPSE, mitral annular plane systolic excursion; MVO,
microvascular obstruction.
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due to breathing artefact. Therefore 44 patients were
included in the statistical analysis. Patient characteristics
are shown in table 1. Infarct characteristics on CMR are
listed in table 2. No gender-based differences in
characteristics were present (p>0.1 for all).
Baseline data
The mean EF of the study cohort was 48±10%, septal
MAPSE was 9.6±2.9 mm, lateral-MAPSE 11±2.3 mm and
averaged-MAPSE of 10.3±2.1 mm.
Twenty-six (59%) patients had MVO and 25 had IMH.
No patient had IMH without MVO. Averaged-MAPSE for
patients with MVO was signiﬁcantly lower than for
patients without MVO (9.3±0.3 mm vs 11.7±0.4 mm;
p<0.001). Similarly, in patients with IMH, MAPSE was
signiﬁcantly lower than in those without IMH (9.2
±0.3 mm vs 11.8±0.4 mm; p<0.001) (ﬁgure 3). On linear
regression analysis, using the variables in table 3, the
presence of IMH (β= −0.65, p<0.001) and MVO (β=
−0.57, p<0.001) demonstrated the strongest association
with averaged-MAPSE (table 3). The size of MVO corre-
lated negatively with averaged-MAPSE (r=−0.420,
p=0.03). Infarct location did not inﬂuence
medial-MAPSE (p=0.316), lateral-MAPSE (p=0.770) or
averaged-MAPSE (p=0.391). The area under the curve
(AUC) for determining the presence of MVO by
averaged-MAPSE was 0.84 (95% CI 0.70 to 0.93;
p<0.001) and for IMH was 0.88 (95% CI 0.77 to 0.96;
p<0.001) (ﬁgure 4). The optimal cut-off value deter-
mined by the Youden index for averaged-MAPSE was
10.6 mm for the detection of MVO (sensitivity 88.5%
and speciﬁcity 72.2%) and IMH (sensitivity 92.0% and
speciﬁcity 73.7%).23
Follow-up data
Thirty-eight of 44 patients underwent day-90 CMR, while
six patients refused follow-up scans. All 38 patients scans
were of good quality and could be analysed. All patients
had complete resolution of MVO and IMH on 90-day
scans. Infarct volume reduced from 14.1±11.8 mLs at base-
line to 8.2±6.7 mLs (p<0.001) at follow-up. As compared
to baseline, EF improved by 21±22% and averaged-MAPSE
improved by 28±22% (p<0.001 for each). On linear regres-
sion analysis taking into account day-2 CMR parameters
(LVEDV, LVESV, averaged-MAPSE, MVO, IMH), LVESV at
day-2 showed the strongest correlation with day-90 EF
(r=0.717, p<0.001).
Of 38 patients with follow-up data, 9 patients (24%)
demonstrated adverse left ventricular remodelling. LV
remodelling showed no signiﬁcant association with day-2
averaged-MAPSE (AUC 0.62, 95% CI 0.44 to 0.77,
p=0.22) (ﬁgure 4C).
Observer variability
On intraobserver analysis, the means of septal MAPSE
(8.52±2.2 mm vs 8.54±2.1 mm; p=0.87, CoV 4%),
lateral-MAPSE (9.97±2.2 mm vs 9.99±1.9 mm; p=0.92,
CoV 5.9%) and septal MAPSE (9.24±1.8 mm vs 9.27
±1.8 mm; p=0.88, CoV 4.1%) were similar.
On inter observer analysis, the means of septal MAPSE
were (9.1±2.4 mm vs 9.3±2.2 mm; p=0.49, CoV of 8.3%),
lateral-MAPSE (11.1±2.4 mm vs 11.5±2 mm; p=0.37, CoV
8.4%) and averaged-MAPSE (10.4±1.8 mm vs 10.1
±1.8 mm; p=0.25, CoV 5.9%).
DISCUSSION
This study demonstrates that longitudinal LV function
measured by averaged-MAPSE on CMR is strongly asso-
ciated with the presence of MVO and IMH. Moreover,
the size of MVO adversely affects averaged-MAPSE.
MAPSE is a well-established and endorsed parameter
of global LV longitudinal function in echocardiography.
Table 1 Patient characteristics
Patient characteristic
n 44
Age, years 58.3±11.4
Male 37 (84%)
Body mass index, kg/m2 28.2±3.5
Current smoker 24 (55%)
Hypertension 11 (25%)
Hypercholesterolemia 13 (30%)
Diabetes mellitus 6 (14%)
Pain to balloon time, min (median (IQR)) 213 (268)
TIMI flow grade 0 or 1 pre-PCI 40 (91%)
TIMI flow grade 3 post PCI 42 (95%)
Peak troponin I, ng/L (median) >50 000
Peak CK, IU/L (median (IQR)) 615 (1510)
Infarct territory
Anterior 20 (45%)
Inferior 18 (41%)
Lateral 6 (14%)
Data as mean±SD or n (%) unless indicated.
CK, creatine kinase; PCI, percutaneous coronary intervention;
PPCI, primary percutaneous coronary intervention; TIMI, flow
grades based on results of the Thrombolysis In Myocardial
Infarction trial.
Table 2 Infarct characteristics at baseline
Characteristic First Scan
Ejection fraction, % 48±10
LV EDVi, mL/m2 82±16
LV ESVi, mL/m2 42±12
LV indexed mass, g/m2 65±14
LGE infarct volume, mL 15±12
LGE MVO volume, mL 3±5
MAPSE (septal) 9.6±2.9
MAPSE (lateral) 11±2.3
MAPSE (averaged) 10.3±2.1
MVO present 26 (59%)
n=44. Data as mean±SD. LV measurements are indexed to body
surface area, infarct volumes are unindexed.
LGE, late gadolinium enhancement; LV, left ventricular; LV EDVi,
left ventricular end diastolic volume (indexed); LV ESVi, left
ventricular end systolic volume (indexed).
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A lower absolute value of MAPSE in post-AMI is a poor
prognostic marker.12 Previous studies using speckle
tracking echocardiography in AMI patients have shown
that MVO determined on CMR adversely affects global
longitudinal strain (GLS) on echocardiography.24 25
However, with current technology, there remains
marked variability in GLS depending on the measure-
ment algorithms on the vendor’s software and also on
the sample volume deﬁnition. Therefore, no speciﬁc
vendor independent normal ranges are provided in
current American and European guidelines.26 MAPSE,
on the contrary, is a vendor independent parameter of
global longitudinal function, which can also be
measured from standard cine CMR images.27 Limited
data are available in the literature on the association of
MAPSE assessed by CMR to MVO and none for IMH.
This study demonstrated that reduced averaged-MAPSE
is associated the presence of MVO/IMH.
Myocardial deformation, including global longitudinal
function (GLS), can also be studied on CMR using
strain measurements derived from tissue tagging or
feature tracking (FT). Tagging derived strain requires
longer scanning time and both methods need dedicated
postprocessing software to analyse the data. In a
post-AMI study comparing tagging to FT-derived strain,
FT-derived strain was quicker to analyse, tracked
Figure 3 Box-plot of averaged-MAPSE with or without the presence of (A) MVO or (B) IMH. IMH, intramyocardial haemorrhage;
MAPSE, mitral annular plane systolic excursion; MVO, microvascular obstruction.
Table 3 Univariate and multivariate analysis of longitudinal parameters of LV function to CMR derived clinical and prognostic
markers
MAPSE (septal)
p value
MAPSE (lateral)
p value
MAPSE (averaged)
p value (β)
UV MV UV MV UV MV
Demographics
Age 0.36 0.11 0.13
Sex 0.27 0.44 0.74
Smoking history 0.79 0.86 0.77
Hypertension 0.64 0.65 0.94
Hypercholesterolemia 0.81 0.69 0.95
Diabetes mellitus 0.002 0.006 0.60 0.01 0.05
CK 0.26 0.72 0.33
Pain-balloon time 0.0 0.004 0.26 0.45
CMR parameters
Anterior infarct 0.33 0.91 0.54
LVEDVi 0.95 0.97 0.98
SVi 0.06 0.187 0.27 0.06 0.207
Ejection fraction 0.02 0.246 0.09 0.82 0.01 0.293
Infarct mass 0.11 0.49 0.48
Infarct volume 0.69 0.23 0.35
MVO 0.002 0.415 0.001 0.36 <0.01 (−0.57) 0.229
IMH <0.01 <0.01 <0.01 <0.01 <0.01 (−0.65) <0.001
CK, creatine kinase; CMR, cardiovascular MR; IMH, intramyocardial haemorrhage; LV EDVi, left ventricular end diastolic volume (indexed);
MAPSE, mitral annular plane systolic excursion; MV, multivariate; MVO, microvascular obstruction; SVi, systolic volume (indexed); UN,
univariate.
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myocardium better, had better interobserver variability
and stronger correlations with infarct and oedema.28
Furthermore, similar to echocardiography, there
remains signiﬁcant intervendor and intersoftware vari-
ability in FT-derived strain.29 Hence, MAPSE remains the
quickest, vendor-software independent and reproducible
method to assess GLS from routinely acquired cine
images.
Our data conﬁrm previous observations of a weak
association of LV remodelling with LV global longitu-
dinal function,30 31 due to the fact that longitudinal
function of the LV is driven mainly by the endocardial
ﬁbres (ﬁgure 1). Also, longitudinal ﬁbres contribute
only 19% to the total stroke volume of the LV versus
circumferential ﬁbres which contribute 43%.32 Hence,
even though MAPSE may be more adversely affected in
patients with MVO or IMH, MAPSE does not necessar-
ily result in LV remodelling. LV remodelling is directly
proportional to the infarct transmural extent and
hence more related to strain parameters, which involve
more mid, and epicardial ﬁbres, for example, circum-
ferential strain.
Clinical implications
Our ﬁndings have potential clinical implications and
suggest that MAPSE can be performed easily on stand-
ard cine CMR images, without the need for additional
MR tissue characterisation techniques (T2W and T2*)
and analysis methods. As shown, MAPSE can potentially
predict the presence of MVO/IMH early after primary
PCI for STEMI. MVO and IMH are independent histo-
pathological and cardiac imaging markers of adverse
prognosis and their early detection from routinely
acquired CMR images by MAPSE may help tailor appro-
priate pharmacological interventions. Patients with previ-
ous history of allergy to gadolinium-based contrast or
patients with end-stage renal failure may also beneﬁt
from this technique to predict the likelihood of pres-
ence of MVO or IMH. MAPSE can also be evaluated by
bedside M-Mode echocardiography in post infarct
patients and it could potentially act as a gatekeeper for
further assessment by CMR.
Study limitations
The study sample size is relatively small and the results
are therefore mainly hypothesis generating. In this study,
we also excluded patients who were unstable post PPCI
(higher Killip class, not able to lie ﬂat because of short-
ness of breath and use of invasive monitoring). These
patients are more likely to represent a higher risk group
with more adverse prognosis. In our study population,
the majority of patients with MVO had IMH and only one
patient with MVO had no IMH. Hence, it was not pos-
sible to investigate whether there remains an incremental
value of using averaged-MAPSE for the detection of IMH.
Additionally, the absolute measure of MAPSE does not
take the total length of the LV into account, which is
potentially a better measure of LV longitudinal function
as it measures absolute change in longitudinal para-
meters. In some diseases, like apical pericardial effusion,
the apex may be mobile and this may inﬂuence the longi-
tudinal function independently.
CONCLUSIONS
Averaged-MAPSE, evaluated using cine CMR is strongly
associated with the presence of MVO and IMH when
compared to advanced MR relaxometry techniques
(T2w and T2*), in patients with recent reperfused AMI.
Global left ventricular longitudinal function, assessed by
averaged-MAPSE, is feasible and shows high reproduci-
bility. In this study, the size of MVO adversely affected
averaged-MAPSE. However, averaged-MAPSE did not
show any signiﬁcant correlation with left ventricular
remodelling.
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